102 related articles for article (PubMed ID: 1399941)
21. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
Drabu YJ; Blakemore PH
Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
[TBL] [Abstract][Full Text] [Related]
22. In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus.
Mutton KJ; Andrew JH
Chemotherapy; 1983; 29(3):218-24. PubMed ID: 6409520
[TBL] [Abstract][Full Text] [Related]
23. Methicillin-susceptible Staphylococcus aureus ST398-t571 harbouring the macrolide-lincosamide-streptogramin B resistance gene erm(T) in Belgian hospitals.
Vandendriessche S; Kadlec K; Schwarz S; Denis O
J Antimicrob Chemother; 2011 Nov; 66(11):2455-9. PubMed ID: 21868413
[TBL] [Abstract][Full Text] [Related]
24. Postantibiotic effect and postantibiotic sub-minimum inhibitory concentration effect of valnemulin against Staphylococcus aureus isolates from swine and chickens.
Zhao DH; Yu Y; Zhou YF; Shi W; Deng H; Liu YH
Lett Appl Microbiol; 2014 Feb; 58(2):150-5. PubMed ID: 24117872
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus].
Rolin O; Bouanchaud DH
Pathol Biol (Paris); 1989 May; 37(5):375-7. PubMed ID: 2780094
[TBL] [Abstract][Full Text] [Related]
26. In-vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci.
Pechère JC
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():15-8. PubMed ID: 1399945
[TBL] [Abstract][Full Text] [Related]
27. In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).
Ling TK; Fung KS; Cheng AF
Chemotherapy; 2001; 47(4):243-9. PubMed ID: 11399860
[TBL] [Abstract][Full Text] [Related]
28. In-vitro activity of streptogramin RP 59500 against staphylococci, including bactericidal kinetic studies.
Hoban DJ; Weshnoweski B; Palatnick L; Zhanel CG; Davidson RJ
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():59-65. PubMed ID: 1399952
[TBL] [Abstract][Full Text] [Related]
29. [In vitro study of strains of Staphylococcus: choice of an antibiotic].
Messmer JC; Lecaillon-Thibon E; Soler H
Sem Hop; 1984 May; 60(19):1329-32. PubMed ID: 6326323
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
[TBL] [Abstract][Full Text] [Related]
31. In vitro post-antibiotic effect of fluoroquinolones, macrolides, beta-lactams, tetracyclines, vancomycin, clindamycin, linezolid, chloramphenicol, quinupristin/dalfopristin and rifampicin on Bacillus anthracis.
Athamna A; Athamna M; Medlej B; Bast DJ; Rubinstein E
J Antimicrob Chemother; 2004 Apr; 53(4):609-15. PubMed ID: 14998982
[TBL] [Abstract][Full Text] [Related]
32. D test: a simple test with big implication for Staphylococcus aureus macrolide-lincosamide-streptograminB resistance pattern.
Shrestha B; Rana SS
Nepal Med Coll J; 2014 Sep; 16(1):88-94. PubMed ID: 25799821
[TBL] [Abstract][Full Text] [Related]
33. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
Kusuma CM; Kokai-Kun JF
Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates.
Millán L; Cerdá P; Rubio MC; Goñi P; Canales M; Capilla S; Oca M; Gómez-Lus R
J Chemother; 2004 Jun; 16(3):230-7. PubMed ID: 15330317
[TBL] [Abstract][Full Text] [Related]
35. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
36. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
[TBL] [Abstract][Full Text] [Related]
37. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
Dutta GN; Devriese LA
Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
[TBL] [Abstract][Full Text] [Related]
38. A collaborative study of the in-vitro sensitivity to RP 59500 of bacteria isolated in seven hospitals in France.
Soussy CJ; Acar JF; Cluzel R; Courvalin P; Duval J; Fleurette J; Megraud F; Meyran M; Thabaut A
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():53-8. PubMed ID: 1399951
[TBL] [Abstract][Full Text] [Related]
39. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
[TBL] [Abstract][Full Text] [Related]
40. erm(C) is the predominant genetic determinant for the expression of resistance to macrolides among methicillin-resistant Staphylococcus aureus clinical isolates in Greece.
Spiliopoulou I; Petinaki E; Papandreou P; Dimitracopoulos G
J Antimicrob Chemother; 2004 May; 53(5):814-7. PubMed ID: 15056638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
